Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Niche and neutral effects of acquired immunity permit coexistence of pneumococcal serotypes.

Cobey S, Lipsitch M.

Science. 2012 Mar 16;335(6074):1376-80. doi: 10.1126/science.1215947. Epub 2012 Mar 1.

2.

Effect of pneumococcal conjugate vaccination on serotype-specific carriage and invasive disease in England: a cross-sectional study.

Flasche S, Van Hoek AJ, Sheasby E, Waight P, Andrews N, Sheppard C, George R, Miller E.

PLoS Med. 2011 Apr;8(4):e1001017. doi: 10.1371/journal.pmed.1001017. Epub 2011 Apr 5.

3.

Pneumococcal capsular polysaccharide structure predicts serotype prevalence.

Weinberger DM, Trzciński K, Lu YJ, Bogaert D, Brandes A, Galagan J, Anderson PW, Malley R, Lipsitch M.

PLoS Pathog. 2009 Jun;5(6):e1000476. doi: 10.1371/journal.ppat.1000476. Epub 2009 Jun 12.

4.

Declining serotype coverage of new pneumococcal conjugate vaccines relating to the carriage of Streptococcus pneumoniae in young children.

Tocheva AS, Jefferies JM, Rubery H, Bennett J, Afimeke G, Garland J, Christodoulides M, Faust SN, Clarke SC.

Vaccine. 2011 Jun 10;29(26):4400-4. doi: 10.1016/j.vaccine.2011.04.004. Epub 2011 Apr 17.

PMID:
21504773
5.

High nasopharyngeal carriage of non-vaccine serotypes in Western Australian aboriginal people following 10 years of pneumococcal conjugate vaccination.

Collins DA, Hoskins A, Bowman J, Jones J, Stemberger NA, Richmond PC, Leach AJ, Lehmann D.

PLoS One. 2013 Dec 3;8(12):e82280. doi: 10.1371/journal.pone.0082280. eCollection 2013.

6.

Impaired innate and adaptive immunity to Streptococcus pneumoniae and its effect on colonization in an infant mouse model.

Bogaert D, Weinberger D, Thompson C, Lipsitch M, Malley R.

Infect Immun. 2009 Apr;77(4):1613-22. doi: 10.1128/IAI.00871-08. Epub 2009 Jan 21.

7.

Serotype-related variation in susceptibility to complement deposition and opsonophagocytosis among clinical isolates of Streptococcus pneumoniae.

Melin M, Trzciński K, Antonio M, Meri S, Adegbola R, Kaijalainen T, Käyhty H, Väkeväinen M.

Infect Immun. 2010 Dec;78(12):5252-61. doi: 10.1128/IAI.00739-10. Epub 2010 Sep 20.

8.

The influence of competition and vaccination on the coexistence of two pneumococcal serotypes.

Zhang Y, Auranen K, Eichner M.

Epidemiol Infect. 2004 Dec;132(6):1073-81.

9.
10.

The effect of an alternative reduced-dose infant schedule and a second year catch-up schedule with 7-valent pneumococcal conjugate vaccine on pneumococcal carriage: a randomized controlled trial.

Dagan R, Givon-Lavi N, Porat N, Greenberg D.

Vaccine. 2012 Jul 20;30(34):5132-40. doi: 10.1016/j.vaccine.2012.05.059. Epub 2012 Jun 6.

PMID:
22683519
11.

Dynamic models of pneumococcal carriage and the impact of the Heptavalent Pneumococcal Conjugate Vaccine on invasive pneumococcal disease.

Melegaro A, Choi YH, George R, Edmunds WJ, Miller E, Gay NJ.

BMC Infect Dis. 2010 Apr 8;10:90. doi: 10.1186/1471-2334-10-90.

12.

Cross-sectional study of nasopharyngeal carriage of Streptococcus pneumoniae in human immunodeficiency virus-infected adults in the conjugate vaccine era.

Onwubiko C, Swiatlo E, McDaniel LS.

J Clin Microbiol. 2008 Nov;46(11):3621-5. doi: 10.1128/JCM.01245-08. Epub 2008 Sep 24.

13.

Epidemiologic evidence for serotype-specific acquired immunity to pneumococcal carriage.

Weinberger DM, Dagan R, Givon-Lavi N, Regev-Yochay G, Malley R, Lipsitch M.

J Infect Dis. 2008 Jun 1;197(11):1511-8. doi: 10.1086/587941.

PMID:
18471062
14.

The immunising effect of pneumococcal nasopharyngeal colonisation; protection against future colonisation and fatal invasive disease.

Richards L, Ferreira DM, Miyaji EN, Andrew PW, Kadioglu A.

Immunobiology. 2010 Apr;215(4):251-63. doi: 10.1016/j.imbio.2009.12.004. Epub 2009 Dec 28.

PMID:
20071053
15.

Carriage of Streptoccoccus pneumoniae 7 years after implementation of vaccination program in a population with very high and long-lasting coverage, Italy.

Ansaldi F, de Florentiis D, Canepa P, Zancolli M, Martini M, Orsi A, Durando P, Icardi G.

Vaccine. 2012 Mar 16;30(13):2288-94. doi: 10.1016/j.vaccine.2012.01.067. Epub 2012 Feb 3.

PMID:
22306795
16.
17.

Pneumococcal vaccines: mechanism of action, impact on epidemiology and adaption of the species.

Pletz MW, Maus U, Krug N, Welte T, Lode H.

Int J Antimicrob Agents. 2008 Sep;32(3):199-206. doi: 10.1016/j.ijantimicag.2008.01.021. Epub 2008 Apr 18. Review.

PMID:
18378430
18.
19.

Carriage and invasive isolates of Streptococcus pneumoniae in Caracas, Venezuela: the relative invasiveness of serotypes and vaccine coverage.

Rivera-Olivero IA, del Nogal B, Sisco MC, Bogaert D, Hermans PW, de Waard JH.

Eur J Clin Microbiol Infect Dis. 2011 Dec;30(12):1489-95. doi: 10.1007/s10096-011-1247-5. Epub 2011 Apr 18.

PMID:
21499972
20.

Modeling the decline in pneumococcal acute otitis media following the introduction of pneumococcal conjugate vaccines in the US.

Shea KM, Weycker D, Stevenson AE, Strutton DR, Pelton SI.

Vaccine. 2011 Oct 19;29(45):8042-8. doi: 10.1016/j.vaccine.2011.08.057. Epub 2011 Aug 24.

PMID:
21871518

Supplemental Content

Support Center